Packaging DetailsCasirivimab/imdevimab, sold under the brand name REGEN-COV among others, is a medicine developed by the American biotechnology company Regeneron Pharmaceuticals. It is an artificial "antibody cocktail" designed to produce resistance against the SARS-CoV-2 coronavirus responsible for the COVID-19 pandemic.The combination of Casirivimab and Imdevimab is an investigational drug product being studied in the US and Canada to treat coronavirus disease, also known as COVID-19. In the US, this product is not FDA-approved; however, it is FDA-authorized for emergency use to treat COVID-19.
Delivery Time5 working days
Product Images
Company Details
Medisat Pharmaceuticals is one of the established PCD companies in India, based out of Tamil Nadu and we sincerely aim to add value to human life. Medisat Pharmaceuticals provides business opportunities to the pharma professionals from all across the globe.
Nature of Business Manufacturer / Exporter / Supplier / Retailer / Distributor / Importer / Buying House
Number of Employees20 - 50
Year of Establishment2017
Tell us your Buy Requirement to Get Instant Response